Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel Hargest

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Cancer Genomics & Proteomics|September 20, 2012
Expression of signal-induced proliferation-associated gene 1 (SIPA1), a RapGTPase-activating protein, is increased in colorectal cancer and has diverse effects on functions of colorectal cancer cellsKe Ji, Lin Ye, Anne-Marie Toms, et al.
International Journal of Molecular Medicine|April 3, 2013
Potential implication of IL-24 in lymphangiogenesis of human breast cancerNatasha C Frewer, Lin Ye, Ping-Hui Sun, et al.
Oncology Reports|November 26, 2013
Death associated protein 1 is correlated with the clinical outcome of patients with colorectal cancer and has a role in the regulation of cell deathYongning Jia, Lin Ye, Ke Ji, et al.
Cancer Immunology, Immunotherapy : CII|November 9, 2018
The nature of the human T cell response to the cancer antigen 5T4 is determined by the balance of regulatory and inflammatory T cells of the same antigen-specificity: implications for vaccine designMatthieu Besneux, Alexander Greenshields-Watson, Martin J Scurr, et al.
Bulletin of the World Health Organization|March 3, 2025
Global burden of emergency and operative conditions: an analysis of Global Burden of Disease data, 2011-2019Sabrina Wimmer, Shreeja Sarabu, Emilie Calvello Hynes, et al.
BMC Health Services Research|September 4, 2023
Identifying critical gaps in research to advance global surgery by 2030: a systematic mapping reviewMeskerem Aleka Kebede, Deng Simon Garang Tor, Tesfamariam Aklilu, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 15, 2013
Gene silencing following siRNA delivery to skin via coated steel microneedles: In vitro and in vivo proof-of-conceptRosalind H E Chong, Emilio Gonzalez-Gonzalez, Maria F Lara, et al.
International Journal of Oncology|November 16, 2022
Death associated protein‑3 (DAP3) and DAP3 binding cell death enhancer‑1 (DELE1) in human colorectal cancer, and their impacts on clinical outcome and chemoresistanceLaijian Sui, Jianyuan Zeng, Huishan Zhao, et al.
Cancer Immunology Research|January 11, 2014
Escalating regulation of 5T4-specific IFN-γ<sup>+</sup> CD4<sup>+</sup> T cells distinguishes colorectal cancer patients from healthy controls and provides a target for <i>in vivo</i> therapyMartin Scurr, Anja Bloom, Tom Pembroke, et al.
The Surgeon : Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland|April 23, 2024
Association between psoas major muscle mass and CPET performance and long-term survival following major colorectal surgery: A retrospective cohort studyShahab Hajibandeh, Iain Gilham, Winnie Tam, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Cancer Genomics & Proteomics|September 20, 2012
Expression of signal-induced proliferation-associated gene 1 (SIPA1), a RapGTPase-activating protein, is increased in colorectal cancer and has diverse effects on functions of colorectal cancer cellsKe Ji, Lin Ye, Anne-Marie Toms, et al.
International Journal of Molecular Medicine|April 3, 2013
Potential implication of IL-24 in lymphangiogenesis of human breast cancerNatasha C Frewer, Lin Ye, Ping-Hui Sun, et al.
Oncology Reports|November 26, 2013
Death associated protein 1 is correlated with the clinical outcome of patients with colorectal cancer and has a role in the regulation of cell deathYongning Jia, Lin Ye, Ke Ji, et al.
Cancer Immunology, Immunotherapy : CII|November 9, 2018
The nature of the human T cell response to the cancer antigen 5T4 is determined by the balance of regulatory and inflammatory T cells of the same antigen-specificity: implications for vaccine designMatthieu Besneux, Alexander Greenshields-Watson, Martin J Scurr, et al.
Bulletin of the World Health Organization|March 3, 2025
Global burden of emergency and operative conditions: an analysis of Global Burden of Disease data, 2011-2019Sabrina Wimmer, Shreeja Sarabu, Emilie Calvello Hynes, et al.
BMC Health Services Research|September 4, 2023
Identifying critical gaps in research to advance global surgery by 2030: a systematic mapping reviewMeskerem Aleka Kebede, Deng Simon Garang Tor, Tesfamariam Aklilu, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 15, 2013
Gene silencing following siRNA delivery to skin via coated steel microneedles: In vitro and in vivo proof-of-conceptRosalind H E Chong, Emilio Gonzalez-Gonzalez, Maria F Lara, et al.
International Journal of Oncology|November 16, 2022
Death associated protein‑3 (DAP3) and DAP3 binding cell death enhancer‑1 (DELE1) in human colorectal cancer, and their impacts on clinical outcome and chemoresistanceLaijian Sui, Jianyuan Zeng, Huishan Zhao, et al.
Cancer Immunology Research|January 11, 2014
Escalating regulation of 5T4-specific IFN-γ<sup>+</sup> CD4<sup>+</sup> T cells distinguishes colorectal cancer patients from healthy controls and provides a target for <i>in vivo</i> therapyMartin Scurr, Anja Bloom, Tom Pembroke, et al.
The Surgeon : Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland|April 23, 2024
Association between psoas major muscle mass and CPET performance and long-term survival following major colorectal surgery: A retrospective cohort studyShahab Hajibandeh, Iain Gilham, Winnie Tam, et al.
Pageof 6